Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2020 Q1- Text added to 2020 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
New words:
ACERA, admitted, Alameda, alfa, andexanet, antifraud, AP, Aradhana, arrest, asterisk, Australia, Cal, California, capped, captive, cardiac, cerdulatinib, Certificate, coagulation, Codification, commensurate, contend, County, cytolytic, device, dual, duly, endorsement, entertainment, exhausted, exhibit, exploring, exquisitely, fit, gradually, Hantson, Hayden, IgAN, Inline, insignificant, ischemic, iXBRL, kinase, Language, LN, low, Ludwig, McCutcheon, microanglopathy, misleading, Nephropathy, Northern, obsolescence, Odyssey, omitted, Ondexxa, outlined, Oxley, page, partnership, Pennsylvania, physical, preexisting, proteinuria, proximity, PTAB, queue, RAR, ravulizumab, reconfigured, registrant, remitted, residual, revealed, robust, Sarin, Southeastern, sudden, Switzerland, thereunto, thrombolic, tiered, tradename, trough, tyrosine, undersigned, Unlimited, usage, verify, vi, viable, Vice, warrant, wholly, wrongdoing, XBRL
Removed:
BioPharma, book, close, notified, reach, receipt, Rodino, Synageva, transformation, UNREGISTERED
Valuein 2020 Q1 filing- Value in 2020 Q2 filing
Original filings
Filing view